Long-term oxygen therapy has been proven to improve survival in COPD patients with severely impaired oxygenation. However, does the COPD patient with moderately impaired oxygenation also benefit from supplemental long-term oxygen therapy? The Long-Term Oxygen Treatment Trial (LOTT), a randomized clinical trial published in 2016, was designed to evaluate the efficacy of supplemental oxygen for this patient population. This presentation will discuss the design and results of the multi-center LOTT and the implications on patient care.
Presented by Jerry Krishnan, MD, PhD
This Live AARC webcast is approved for 1.0 CRCE
***To download the abstract of the study that will be discussed please use the link below***
The Long-Term Oxygen Treatment Trial Research Group. A randomized trial of long-term oxygen for COPD with moderate desaturation. NEJM 2016;375(17):1617-1627.
This webcast is sponsored by an unrestricted educational grant from ResMed Inc.
Live Webcast Information
June 06, 2017 2:00 PM Eastern
1:00 PM Central, 12:00 PM Mountain, 11:00 AM Pacific
June 06, 2017 11:55 PM
Registration Time Remaining:
9 days, 10 hours
Senior Active Price:
Senior Associate Price:
WEB Sign-up Price:
American Association for Respiratory Care
Continuing Respiratory Care Education: 1.00
Senior Active: $0.00
Senior Associate: $0.00
WEB Sign-up: $15.00
Full Price: $15.00